nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—hypertension—focal segmental glomerulosclerosis	0.496	1	CtDrD
Lisinopril—ACE—focal segmental glomerulosclerosis	0.355	1	CbGaD
Lisinopril—ACE2—nephron—focal segmental glomerulosclerosis	0.0158	0.306	CbGeAlD
Lisinopril—ACE—arteriole—focal segmental glomerulosclerosis	0.0118	0.23	CbGeAlD
Lisinopril—Abnormal chest sounds NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.136	CcSEcCtD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.00575	0.142	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—focal segmental glomerulosclerosis	0.00516	0.127	CbGpPWpGaD
Lisinopril—ACE—nephron—focal segmental glomerulosclerosis	0.00515	0.1	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.00491	0.121	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.00442	0.109	CbGpPWpGaD
Lisinopril—ACE2—nephron tubule—focal segmental glomerulosclerosis	0.0034	0.0661	CbGeAlD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—AGT—focal segmental glomerulosclerosis	0.00327	0.0806	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00311	0.0768	CbGpPWpGaD
Lisinopril—ACE2—kidney—focal segmental glomerulosclerosis	0.00299	0.058	CbGeAlD
Lisinopril—ACE2—cortex of kidney—focal segmental glomerulosclerosis	0.00291	0.0565	CbGeAlD
Lisinopril—Breath sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.0513	CcSEcCtD
Lisinopril—ACE—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.00257	0.0634	CbGpPWpGaD
Lisinopril—ACE—endothelium—focal segmental glomerulosclerosis	0.00243	0.0471	CbGeAlD
Lisinopril—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.0377	CcSEcCtD
Lisinopril—ACE—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.00198	0.0487	CbGpPWpGaD
Lisinopril—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0325	CcSEcCtD
Lisinopril—SLC15A1—nephron tubule—focal segmental glomerulosclerosis	0.00155	0.0301	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00151	0.0373	CbGpPWpGaD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—focal segmental glomerulosclerosis	0.00146	0.036	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00139	0.0343	CbGpPWpGaD
Lisinopril—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.0259	CcSEcCtD
Lisinopril—SLC15A1—kidney—focal segmental glomerulosclerosis	0.00136	0.0265	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.00136	0.0334	CbGpPWpGaD
Lisinopril—ACE—nephron tubule—focal segmental glomerulosclerosis	0.00111	0.0216	CbGeAlD
Lisinopril—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0203	CcSEcCtD
Lisinopril—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000985	0.0184	CcSEcCtD
Lisinopril—ACE—kidney—focal segmental glomerulosclerosis	0.000977	0.019	CbGeAlD
Lisinopril—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000972	0.0182	CcSEcCtD
Lisinopril—ACE—cortex of kidney—focal segmental glomerulosclerosis	0.000952	0.0185	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000859	0.0212	CbGpPWpGaD
Lisinopril—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000853	0.016	CcSEcCtD
Lisinopril—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.000835	0.0156	CcSEcCtD
Lisinopril—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000735	0.0138	CcSEcCtD
Lisinopril—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000728	0.0136	CcSEcCtD
Lisinopril—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.000697	0.0131	CcSEcCtD
Lisinopril—ACE—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000675	0.0166	CbGpPWpGaD
Lisinopril—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.0113	CcSEcCtD
Lisinopril—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.0109	CcSEcCtD
Lisinopril—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.0108	CcSEcCtD
Lisinopril—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000562	0.0105	CcSEcCtD
Lisinopril—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000551	0.0103	CcSEcCtD
Lisinopril—Fosinopril—ACE—focal segmental glomerulosclerosis	0.00053	0.149	CrCbGaD
Lisinopril—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000516	0.00966	CcSEcCtD
Lisinopril—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00954	CcSEcCtD
Lisinopril—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.000498	0.00933	CcSEcCtD
Lisinopril—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.000495	0.00928	CcSEcCtD
Lisinopril—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00923	CcSEcCtD
Lisinopril—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.0082	CcSEcCtD
Lisinopril—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000436	0.00816	CcSEcCtD
Lisinopril—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.00805	CcSEcCtD
Lisinopril—Spirapril—ACE—focal segmental glomerulosclerosis	0.000428	0.12	CrCbGaD
Lisinopril—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.000424	0.00794	CcSEcCtD
Lisinopril—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.000424	0.00794	CcSEcCtD
Lisinopril—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000414	0.00776	CcSEcCtD
Lisinopril—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.00769	CcSEcCtD
Lisinopril—Moexipril—ACE—focal segmental glomerulosclerosis	0.00041	0.115	CrCbGaD
Lisinopril—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0004	0.0075	CcSEcCtD
Lisinopril—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000394	0.00737	CcSEcCtD
Lisinopril—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.00734	CcSEcCtD
Lisinopril—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000391	0.0076	CbGeAlD
Lisinopril—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00039	0.00731	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000384	0.00946	CbGpPWpGaD
Lisinopril—Cilazapril—ACE—focal segmental glomerulosclerosis	0.000381	0.107	CrCbGaD
Lisinopril—Quinapril—ACE—focal segmental glomerulosclerosis	0.000381	0.107	CrCbGaD
Lisinopril—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000381	0.00713	CcSEcCtD
Lisinopril—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.000378	0.00708	CcSEcCtD
Lisinopril—Ramipril—ACE—focal segmental glomerulosclerosis	0.000369	0.104	CrCbGaD
Lisinopril—Trandolapril—ACE—focal segmental glomerulosclerosis	0.000369	0.104	CrCbGaD
Lisinopril—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000357	0.00668	CcSEcCtD
Lisinopril—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000344	0.00645	CcSEcCtD
Lisinopril—ABCB1—kidney—focal segmental glomerulosclerosis	0.000344	0.00668	CbGeAlD
Lisinopril—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000343	0.00642	CcSEcCtD
Lisinopril—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000337	0.00631	CcSEcCtD
Lisinopril—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000335	0.00651	CbGeAlD
Lisinopril—Benazepril—ACE—focal segmental glomerulosclerosis	0.000332	0.0932	CrCbGaD
Lisinopril—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000324	0.00606	CcSEcCtD
Lisinopril—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.00604	CcSEcCtD
Lisinopril—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.00601	CcSEcCtD
Lisinopril—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000317	0.00593	CcSEcCtD
Lisinopril—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000308	0.00577	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000306	0.00573	CcSEcCtD
Lisinopril—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.00561	CcSEcCtD
Lisinopril—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000298	0.00558	CcSEcCtD
Lisinopril—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000297	0.00556	CcSEcCtD
Lisinopril—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000295	0.00553	CcSEcCtD
Lisinopril—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000293	0.00548	CcSEcCtD
Lisinopril—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000289	0.00542	CcSEcCtD
Lisinopril—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000289	0.0054	CcSEcCtD
Lisinopril—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000288	0.00539	CcSEcCtD
Lisinopril—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000288	0.00539	CcSEcCtD
Lisinopril—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00536	CcSEcCtD
Lisinopril—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000285	0.00534	CcSEcCtD
Lisinopril—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00028	0.00524	CcSEcCtD
Lisinopril—Enalapril—ACE—focal segmental glomerulosclerosis	0.00028	0.0786	CrCbGaD
Lisinopril—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000278	0.0052	CcSEcCtD
Lisinopril—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00519	CcSEcCtD
Lisinopril—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00516	CcSEcCtD
Lisinopril—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000264	0.00495	CcSEcCtD
Lisinopril—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000264	0.00494	CcSEcCtD
Lisinopril—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.0049	CcSEcCtD
Lisinopril—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00487	CcSEcCtD
Lisinopril—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00484	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000256	0.00631	CbGpPWpGaD
Lisinopril—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.0046	CcSEcCtD
Lisinopril—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000245	0.00458	CcSEcCtD
Lisinopril—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000239	0.00448	CcSEcCtD
Lisinopril—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000238	0.00445	CcSEcCtD
Lisinopril—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00443	CcSEcCtD
Lisinopril—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.00441	CcSEcCtD
Lisinopril—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000233	0.00436	CcSEcCtD
Lisinopril—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.00432	CcSEcCtD
Lisinopril—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0043	CcSEcCtD
Lisinopril—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000226	0.00423	CcSEcCtD
Lisinopril—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000225	0.00422	CcSEcCtD
Lisinopril—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000225	0.00421	CcSEcCtD
Lisinopril—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00417	CcSEcCtD
Lisinopril—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00413	CcSEcCtD
Lisinopril—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000216	0.00405	CcSEcCtD
Lisinopril—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000215	0.00402	CcSEcCtD
Lisinopril—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000213	0.00399	CcSEcCtD
Lisinopril—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000212	0.00397	CcSEcCtD
Lisinopril—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00393	CcSEcCtD
Lisinopril—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.00387	CcSEcCtD
Lisinopril—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000206	0.00386	CcSEcCtD
Lisinopril—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000205	0.00385	CcSEcCtD
Lisinopril—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.0002	0.00375	CcSEcCtD
Lisinopril—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000195	0.00366	CcSEcCtD
Lisinopril—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000195	0.00366	CcSEcCtD
Lisinopril—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000195	0.00366	CcSEcCtD
Lisinopril—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000195	0.00364	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00363	CcSEcCtD
Lisinopril—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00361	CcSEcCtD
Lisinopril—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00358	CcSEcCtD
Lisinopril—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00354	CcSEcCtD
Lisinopril—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000187	0.00351	CcSEcCtD
Lisinopril—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000187	0.00351	CcSEcCtD
Lisinopril—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.00348	CcSEcCtD
Lisinopril—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00343	CcSEcCtD
Lisinopril—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000182	0.00341	CcSEcCtD
Lisinopril—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000181	0.00339	CcSEcCtD
Lisinopril—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000178	0.00334	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000171	0.00319	CcSEcCtD
Lisinopril—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00317	CcSEcCtD
Lisinopril—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000168	0.00315	CcSEcCtD
Lisinopril—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.00313	CcSEcCtD
Lisinopril—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000166	0.00312	CcSEcCtD
Lisinopril—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000165	0.00309	CcSEcCtD
Lisinopril—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.00305	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000162	0.004	CbGpPWpGaD
Lisinopril—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000162	0.00303	CcSEcCtD
Lisinopril—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000161	0.00302	CcSEcCtD
Lisinopril—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.003	CcSEcCtD
Lisinopril—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.003	CcSEcCtD
Lisinopril—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000154	0.00289	CcSEcCtD
Lisinopril—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000153	0.00287	CcSEcCtD
Lisinopril—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000149	0.00279	CcSEcCtD
Lisinopril—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.00277	CcSEcCtD
Lisinopril—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000148	0.00277	CcSEcCtD
Lisinopril—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000138	0.00258	CcSEcCtD
Lisinopril—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00252	CcSEcCtD
Lisinopril—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000132	0.00248	CcSEcCtD
Lisinopril—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000128	0.0024	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000128	0.00316	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.000127	0.00313	CbGpPWpGaD
Lisinopril—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000124	0.00232	CcSEcCtD
Lisinopril—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000119	0.00223	CcSEcCtD
Lisinopril—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000118	0.00221	CcSEcCtD
Lisinopril—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000118	0.00221	CcSEcCtD
Lisinopril—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000117	0.0022	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000113	0.00279	CbGpPWpGaD
Lisinopril—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000111	0.00208	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000111	0.00273	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	9.49e-05	0.00234	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	8.58e-05	0.00212	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	8.45e-05	0.00208	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	8.4e-05	0.00207	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—focal segmental glomerulosclerosis	7.82e-05	0.022	CrCbGaD
Lisinopril—ACE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	7.25e-05	0.00179	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	7.07e-05	0.00174	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	6.97e-05	0.00172	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	5.68e-05	0.0014	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	4.27e-05	0.00105	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	3.87e-05	0.000954	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.54e-05	0.000874	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.9e-05	0.000715	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.91e-05	0.000471	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.4e-05	0.000345	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.23e-05	0.000304	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.2e-05	0.000295	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.14e-05	0.00028	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	8.55e-06	0.000211	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	7.31e-06	0.00018	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	5.61e-06	0.000138	CbGpPWpGaD
